WASHINGTON (Reuters) - U.S. trials of Sanofi- Pasteur SA's and CSL Ltd's H1N1 swine flu vaccines confirm that only one dose is needed to protect people, U.S. health officials said on Friday.
"I am very pleased today to be able to tell you that the initial results from the NIH (National Institutes of Health) sponsored trial corroborate and reinforce the findings from the companies," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a news conference.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
